Variables | Cluster 1 | Cluster 2 | Cluster 3 | Cluster 4 | P value |
---|---|---|---|---|---|
New-onset BHR, n (%) | 8/21 (38.1) | 1/17 (5.9) | 3/5 (60.0) | 5/64 (7.8)* | <0.001 |
Persistence of BHR, n (%) | 12/20 (60.0) | 1/7 (14.3) | 7/15 (46.7) | 2/22 (9.1)* | <0.002 |
Remission of BHR, n (%) | 8/20 (40.0) | 6/7 (85.7) | 8/15 (53.3) | 20/22 (90.9)* | 0.002 |
Wheezing in the previous 12 months at follow-up, n (%) | 4/23 (17.4) | 10/26 (38.5) | 13/24 (54.2) | 3/25 (12.0)†| 0.005 |
New-onset AR, n (%) | 9/18 (50.0) | 6/9 (66.7) | 7/15 (46.7) | 15/60 (25.0) | 0.026 |
New sensitization on SPT | 13/42 (31.0) | 4/26 (15.4) | 6/23 (26.1) | 27/91 (29.7) | 0.493 |